Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 47

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Comparison of Skin Substitutes for Acute and Chronic Wound Management

Bay, Caroline, Chizmar, Zachary, Reece, Edward M., Yu, Jessie Z., Winocour, Julian, Vorstenbosch, Joshua, Winocour, Sebastian·2021·Seminars in Plastic Surgery
DOI 10.1055/s-0041-1731463
Open this paper in CoChat — free account

Abstract

Chronic and acute wounds, such as diabetic foot ulcers and burns, respectively, can be difficult to treat, especially when autologous skin transplantations are unavailable. Skin substitutes can be used as a treatment alternative by providing the structural elements and growth factors necessary for reepithelialization and revascularization from a nonautologous source. As of 2020, there are 76 commercially available skin substitute products; this article provides a review of the relevant literature related to the major categories of skin substitutes available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0041-1731463

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 77

  1. S Shahrokhi, Skin substitutes
  2. M N Nicholas, 2017, Current status and future of skin substitutes for chronic wound healing, J Cutan Med Surg, 21, 23, 10.1177/1203475416664037 · DOI
  3. D Snyder, Skin substitutes for treating chronic wounds [Internet]
  4. E Davison-Kotler, 2018, A universal classification system of skin substitutes inspired by factorial design, Tissue Eng Part B Rev, 24, 279, 10.1089/ten.teb.2017.0477 · DOI
  5. M E Braza, 2021, Split-thickness skin grafts
  6. J Leon-Villapalos, Skin autografting
  7. M L Ramsey, 2021, Full thickness skin grafts
  8. W L Hickerson, 2019, Twenty-five years' experience and beyond with cultured epidermal autografts for coverage of large burn wounds in adult and pediatric patients, 1989–2015, J Burn Care Res, 40, 157, 10.1093/jbcr/iry061 · DOI
  9. Epicel (cultured epidermal autografts)
  10. V Ronfard, 2000, Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix, Transplantation, 70, 1588, 10.1097/00007890-200012150-00009 · DOI
  11. J Leon-Villapalos, Overview of surgical procedures used in the management of burn injuries
  12. S Dhivya, 2015, Wound dressings - a review, Biomedicine (Taipei), 5, 22, 10.7603/s40681-015-0022-9 · DOI · Paper page
  13. J M Bullocks, 2014, DermACELL: a novel and biocompatible acellular dermal matrix in tissue expander and implant-based breast reconstruction, Eur J Plast Surg, 37, 529, 10.1007/s00238-014-0995-8 · DOI
  14. A Arnaout, 2020, A randomized controlled trial comparing Alloderm-RTU with DermACELL in immediate subpectoral implant-based breast reconstruction, Curr Oncol, 28, 184, 10.3390/curroncol28010020 · DOI
  15. B A Pruitt Jr, 1984, Characteristics and uses of biologic dressings and skin substitutes, Arch Surg, 119, 312, 10.1001/archsurg.1984.01390150050013 · DOI
  16. J A Clarke, 1987, HIV transmission and skin grafts, Lancet, 1, 983, 10.1016/S0140-6736(87)90335-7 · DOI
  17. S Cazzell, 2019, A randomized controlled trial comparing a human acellular dermal matrix versus conventional care for the treatmentof venous leg ulcers, Wounds, 31, 68
  18. A E Capito, 2012, Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates, Ann Plast Surg, 68, 495, 10.1097/SAP.0b013e31823b6b01 · DOI
  19. A Reyzelman, 2009, Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study, Int Wound J, 6, 196, 10.1111/j.1742-481X.2009.00585.x · DOI · Paper page
  20. O A Adetayo, 2016, A Meta-analysis of Outcomes Using Acellular Dermal Matrix in Breast and Abdominal Wall Reconstructions: Event Rates and Risk Factors Predictive of Complications, Ann Plast Surg, 77, e31, 10.1097/SAP.0b013e31822afae5 · DOI
  21. S B Glasberg, 2006, Use of regenerative human acellular tissue (AlloDerm) to reconstruct the abdominal wall following pedicle TRAM flap breast reconstruction surgery, Plast Reconstr Surg, 118, 8, 10.1097/01.prs.0000220470.97776.f5 · DOI
  22. M W Clemens, 2012, Acellular dermal matrix in irradiated tissue expander/implant-based breast reconstruction: evidence-based review, Plast Reconstr Surg, 130, 27S, 10.1097/PRS.0b013e318265f690 · DOI
  23. H Greig, 2019, A retrospective review of breast reconstruction outcomes comparing AlloDerm and DermaCELL, JPRAS Open, 22, 19, 10.1016/j.jpra.2019.07.005 · DOI
  24. L A DiDomenico, 2016, Aseptically processed placental membrane improves healing of diabetic foot ulcerations: prospective, randomized clinical trial, Plast Reconstr Surg Glob Open, 4, e1095, 10.1097/GOX.0000000000001095 · DOI
  25. R G Frykberg, 2015, Challenges in the treatment of chronic wounds, Adv Wound Care (New Rochelle), 4, 560, 10.1089/wound.2015.0635 · DOI · Paper page
  26. N Ahuja, 2020, Dehydrated human amnion chorion membrane as treatment for pediatric burns, Adv Wound Care (New Rochelle), 9, 602, 10.1089/wound.2019.0983 · DOI
  27. C Bianchi, 2019, Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft, Int Wound J, 16, 761, 10.1111/iwj.13094 · DOI
  28. W Tettelbach, 2019, A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics, Int Wound J, 16, 19, 10.1111/iwj.12976 · DOI
  29. P Glat, 2019, A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics, Int Wound J, 7, e2371
  30. R J Snyder, 2016, A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer, Wounds, 28, 70
  31. C Bianchi, 2018, A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers, Int Wound J, 15, 114, 10.1111/iwj.12843 · DOI
  32. R S Kirsner, 2015, Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting, Wound Repair Regen, 23, 737, 10.1111/wrr.12332 · DOI
  33. T W King, 2018, Implants and biomaterials, 595
  34. W Koenen, 2011, One-stage reconstruction of deep facial defects with a single layer dermal regeneration template, J Eur Acad Dermatol Venereol, 25, 788, 10.1111/j.1468-3083.2010.03863.x · DOI
  35. T T Nguyen, 1996, Current treatment of severely burned patients, Ann Surg, 223, 14, 10.1097/00000658-199601000-00004 · DOI
  36. N Groos, 2005, Use of an artificial dermis (Integra) for the reconstruction of extensive burn scars in children. About 22 grafts, Eur J Pediatr Surg, 15, 187, 10.1055/s-2004-821215 · DOI
  37. E Dantzer, 2001, Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts, Br J Plast Surg, 54, 659, 10.1054/bjps.2001.3684 · DOI
  38. E-K Yeong, 2012, The treatment of bone exposure in burns by using artificial dermis, Ann Plast Surg, 69, 607, 10.1097/SAP.0b013e318273f845 · DOI
  39. S A Rehim, 2014, Dermal skin substitutes for upper limb reconstruction: current status, indications, and contraindications, Hand Clin, 30, 239, 10.1016/j.hcl.2014.02.001 · DOI
  40. D M Heimbach, 2003, Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment, J Burn Care Rehabil, 24, 42, 10.1097/00004630-200301000-00009 · DOI · Paper page
  41. K Vig, 2017, Advances in skin regeneration using tissue engineering, Int J Mol Sci, 18, E789, 10.3390/ijms18040789 · DOI
  42. I S Whitaker, 2008, A critical evaluation of the use of Biobrane as a biologic skin substitute: a versatile tool for the plastic and reconstructive surgeon, Ann Plast Surg, 60, 333, 10.1097/SAP.0b013e31806bf446 · DOI
  43. M T Pinto Medeiros Dias, 2019, Tilapia fish skin as a new biologic graft for neovaginoplasty in Mayer-Rokitansky-Kuster-Hauser syndrome: a video case report, Fertil Steril, 112, 174, 10.1016/j.fertnstert.2019.04.003 · DOI
  44. K Alam, 2019, Acellular fish skin grafts for management of split thickness donor sites and partial thickness burns: a case series. Mil Med 2019, Mil Med, 184, 16, 10.1093/milmed/usy280 · DOI
  45. E M Lima-Junior, 2019, Innovative treatment using tilapia skin as a xenograft for partial thickness burns after a gunpowder explosion, J Surg Case Rep, 2019, rjz181, 10.1093/jscr/rjz181 · DOI
  46. J Chen, 2019, Fish collagen surgical compress repairing characteristics on wound healing process in vivo, Mar Drugs, 17, E33, 10.3390/md17010033 · DOI
  47. N Badois, 2019, Acellular fish skin matrix on thin-skin graft donor sites: a preliminary study, J Wound Care, 28, 624, 10.12968/jowc.2019.28.9.624 · DOI
  48. R S Kirsner, 2020, Fish skin grafts compared to human amnion/chorion membrane allografts: A double-blind, prospective, randomized clinical trial of acute wound healing, Wound Repair Regen, 28, 75, 10.1111/wrr.12761 · DOI
  49. M TPM Dias, 2020, Neovaginoplasty using Nile tilapia fish skin as a new biologic graft in patients with Mayer-Rokitansky-Küster-Hauser Syndrome, J Minim Invasive Gynecol, 27, 966, 10.1016/j.jmig.2019.09.779 · DOI
  50. S Michael, 2019, Acellular fish skin graft use for diabetic lower extremity wound healing: a retrospective study of 58 ulcerations and a literature review, Wounds, 31, 262
  51. R C Stone, 2017, A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers, Sci Transl Med, 9, eaaf8611, 10.1126/scitranslmed.aaf8611 · DOI
  52. A Veves, 2001, Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial, Diabetes Care, 24, 290, 10.2337/diacare.24.2.290 · DOI · Paper page
  53. H H Sams, 2002, Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience, Dermatol Surg, 28, 698
  54. D W Chang, 2000, Can a tissue-engineered skin graft improve healing of lower extremity foot wounds after revascularization?, Ann Vasc Surg, 14, 44, 10.1007/s100169910008 · DOI
  55. V Falanga, 1998, Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent, Arch Dermatol, 134, 293, 10.1001/archderm.134.3.293 · DOI
  56. M Martinson, 2016, A comparative analysis of skin substitutes used in the management of diabetic foot ulcers, J Wound Care, 25, S8, 10.12968/jowc.2016.25.Sup10.S8 · DOI
  57. J B Rice, 2015, Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers, J Med Econ, 18, 586, 10.3111/13696998.2015.1031793 · DOI
  58. B Samsell, 2019, Health economics for treatment of diabetic foot ulcers: a cost-effectiveness analysis of eight skin substitutes, J Wound Care, 28, S14, 10.12968/jowc.2019.28.Sup9.S14 · DOI
  59. C M Zelen, 2016, Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost, Int Wound J, 13, 272, 10.1111/iwj.12566 · DOI · Paper page
  60. M A Towler, 2018, Randomized, prospective, blinded-enrollment, head-to-head venous leg ulcer healing trial comparing living, bioengineered skin graft substitute (Apligraf) with living, cryopreserved, human skin allograft (TheraSkin), Clin Podiatr Med Surg, 35, 357, 10.1016/j.cpm.2018.02.006 · DOI
  61. A S Landsman, 2011, A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers, Foot Ankle Spec, 4, 29, 10.1177/1938640010387417 · DOI
  62. G C Gurtner, 2020, A retrospective matched-cohort study of 3994 lower extremity wounds of multiple etiologies across 644 institutions comparing a bioactive human skin allograft, TheraSkin, plus standard of care, to standard of care alone, Int Wound J, 17, 55, 10.1111/iwj.13231 · DOI
  63. W A Marston, 2003, The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial, Diabetes Care, 26, 1701, 10.2337/diacare.26.6.1701 · DOI · Paper page
  64. K Harding, 2013, A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (Dermagraft) in patients with venous leg ulcers, Int Wound J, 10, 132, 10.1111/iwj.12053 · DOI
  65. G W Gibbons, 2015, Grafix®, a Cryopreserved Placental Membrane, for the Treatment of Chronic/Stalled Wounds, Adv Wound Care (New Rochelle), 4, 534, 10.1089/wound.2015.0647 · DOI
  66. C E Ananian, 2019, Wound Closure Outcomes Suggest Clinical Equivalency Between Lyopreserved and Cryopreserved Placental Membranes Containing Viable Cells, Adv Wound Care (New Rochelle), 8, 546, 10.1089/wound.2019.1028 · DOI
  67. J N Brantley, 2015, Use of placental membranes for the treatment of chronic diabetic foot ulcers, Adv Wound Care (New Rochelle), 4, 545, 10.1089/wound.2015.0634 · DOI
  68. L A Lavery, 2014, The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial, Int Wound J, 11, 554, 10.1111/iwj.12329 · DOI · Paper page
  69. K M Raspovic, 2018, Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting, Wound Repair Regen, 26, 213, 10.1111/wrr.12635 · DOI
  70. A Barbul, 2020, The health economic impact of living cell tissue products in the treatment of chronic wounds: A retrospective analysis of medicare claims data, Adv Skin Wound Care, 33, 27, 10.1097/01.ASW.0000581588.08281.c1 · DOI
  71. M J Carter, 2014, Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers, Value Health, 17, 801, 10.1016/j.jval.2014.08.001 · DOI
  72. E W Floden, 2011, Biophysical characterization of ovine forestomach extracellular matrix biomaterials, J Biomed Mater Res B Appl Biomater, 96, 67, 10.1002/jbm.b.31740 · DOI
  73. R Raizman, 2020, Prospectivemulticenter evaluation of an advanced extracellular matrix for wound management, Adv Skin Wound Care, 33, 437, 10.1097/01.ASW.0000667052.74087.d6 · DOI
  74. D W-C Chen, 2015, Nanofibers used for delivery of antimicrobial agents, Nanomedicine (Lond), 10, 1959, 10.2217/nnm.15.28 · DOI
  75. T Ahmad, 2020, Development of wound healing scaffolds with precisely-triggered sequential release of therapeutic nanoparticles, Biomater Sci, 10.1039/D0BM01277G · DOI
  76. H E Abaci, 2016, Human skin constructs with spatially controlled vasculature using primary and iPSC-Derived Endothelial Cells, Adv Healthc Mater, 5, 1800, 10.1002/adhm.201500936 · DOI
  77. Q H Phua, 2021, Translational stem cell therapy: vascularized skin grafts in skin repair and regeneration, J Transl Med, 19, 83, 10.1186/s12967-021-02752-2 · DOI

Cited by

Metadata

Authors
Bay, C., Chizmar, Z., Reece, E. M., Yu, J. Z., Winocour, J., Vorstenbosch, J., & Winocour, S.
Affiliations
  • Michael E. DeBakey Department of Surgery, Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
  • Michael E. DeBakey Department of Surgery, Division of General Surgery, Baylor College of Medicine, Houston, Texas
  • Department of Plastic Surgery, Vanderbilt University, Nashville, Tennessee
  • Division of Plastic Surgery, McGill University, Montreal, Canada
Venue
Seminars in Plastic Surgery
Publisher
Georg Thieme Verlag KG
Published
2021-08
Volume
35
Issue
03
Pages
171-180
ISSN
  • 1535-2188
  • 1536-0067
DOI
10.1055/s-0041-1731463
Cited by
47
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.